NCT04939090 2026-04-13
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
Clinical Trials
13 trialsNCT05538897 2026-04-13
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT06979596 2026-04-13
OMAHA-015
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT07462663 2026-04-09
SHAPE-ENDO
Hospital Universitari de Bellvitge
Not yet recruiting
NCT07319429 2026-03-13
FEMUS
Fudan University
Phase 2/3 Recruiting
NCT07436793 2026-02-27
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
New Mexico Cancer Research Alliance
Phase 2 Not yet recruiting
NCT06671548 2026-02-02
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Qilu Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT04576104 2026-01-21
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer
Northwestern University
Phase 2 Active not recruiting
NCT03671811 2026-01-06
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
City of Hope Medical Center
Phase 2 Active not recruiting
NCT06998758 2025-12-12
MATRIX
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Recruiting
NCT07254416 2025-11-28
A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Not yet recruiting
NCT04491643 2025-08-11
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Fudan University
Phase 2 Completed
NCT05316467 2025-08-11
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Fudan University
Phase 2/3 Recruiting